Damora Therapeutics annual depreciation and amortization
2021
2022
2023
2024
2025
Damora Therapeutics Depreciation & Amortization Growth & History (DMRA)
Damora Therapeutics's depreciation and amortization was $22,000 for fiscal 2025.
View full Damora Therapeutics company overviewDamora Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $22,000 | $1,000 | +4.76% |
| 2024 | 2024-12-31 | $21,000 | −$248,000 | −92.19% |
| 2023 | 2023-12-31 | $269,000 | $227,000 | +540.48% |
| 2022 | 2022-12-31 | $42,000 | $22,000 | +110.00% |
| 2021 | 2021-12-31 | $20,000 | — | — |
Damora Therapeutics quarterly depreciation and amortization
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6,000 | $0 | 0.00% |
| Q1 2026 | 2026-03-31 | $5,000 | $0 | 0.00% |
| Q4 2025 | 2025-12-31 | $7,000 | — | — |
| Q3 2025 | 2025-09-30 | $6,000 | $0 | 0.00% |
| Q2 2025 | 2025-06-30 | $6,000 | $1,000 | +20.00% |
| Q1 2025 | 2025-03-31 | $5,000 | $0 | 0.00% |
| Q3 2024 | 2024-09-30 | $6,000 | −$205,000 | −97.16% |
| Q2 2024 | 2024-06-30 | $5,000 | −$12,000 | −70.59% |
| Q1 2024 | 2024-03-31 | $5,000 | −$13,000 | −72.22% |
| Q3 2023 | 2023-09-30 | $211,000 | $205,000 | +3416.67% |
| Q2 2023 | 2023-06-30 | $17,000 | $10,000 | +142.86% |
| Q1 2023 | 2023-03-31 | $18,000 | $10,000 | +125.00% |
| Q3 2022 | 2022-09-30 | $6,000 | −$2,000 | −25.00% |
| Q2 2022 | 2022-06-30 | $7,000 | $5,000 | +250.00% |
| Q1 2022 | 2022-03-31 | $8,000 | $6,000 | +300.00% |
| Q3 2021 | 2021-09-30 | $8,000 | — | — |
| Q2 2021 | 2021-06-30 | $2,000 | — | — |
| Q1 2021 | 2021-03-31 | $2,000 | — | — |
Damora Therapeutics depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Damora Therapeutics's depreciation and amortization increased from $20,000 to $22,000, a change of $2,000. The latest reported quarter, Q2 2026, shows $6,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Damora Therapeutics source filings ↗